BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33679796)

  • 21. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
    Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
    Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver.
    Mason WS; Jilbert AR; Litwin S
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33573130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection.
    Yang PL; Althage A; Chung J; Chisari FV
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13825-30. PubMed ID: 12374864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
    Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
    Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
    Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
    Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
    J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses
    Amblard F; Boucle S; Bassit L; Cox B; Sari O; Tao S; Chen Z; Ozturk T; Verma K; Russell O; Rat V; de Rocquigny H; Fiquet O; Boussand M; Di Santo J; Strick-Marchand H; Schinazi RF
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen.
    Zhang TY; Yuan Q; Zhao JH; Zhang YL; Yuan LZ; Lan Y; Lo YC; Sun CP; Wu CR; Zhang JF; Zhang Y; Cao JL; Guo XR; Liu X; Mo XB; Luo WX; Cheng T; Chen YX; Tao MH; Shih JW; Zhao QJ; Zhang J; Chen PJ; Yuan YA; Xia NS
    Gut; 2016 Apr; 65(4):658-71. PubMed ID: 26423112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.
    Mason WS; Gill US; Litwin S; Zhou Y; Peri S; Pop O; Hong ML; Naik S; Quaglia A; Bertoletti A; Kennedy PT
    Gastroenterology; 2016 Nov; 151(5):986-998.e4. PubMed ID: 27453547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.
    Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M
    J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector.
    Lucifora J; Salvetti A; Marniquet X; Mailly L; Testoni B; Fusil F; Inchauspé A; Michelet M; Michel ML; Levrero M; Cortez P; Baumert TF; Cosset FL; Challier C; Zoulim F; Durantel D
    Antiviral Res; 2017 Sep; 145():14-19. PubMed ID: 28709657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.
    Klein C; Bock CT; Wedemeyer H; Wüstefeld T; Locarnini S; Dienes HP; Kubicka S; Manns MP; Trautwein C
    Gastroenterology; 2003 Jul; 125(1):9-18. PubMed ID: 12851866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models.
    Shen Z; Liu J; Wu J; Zhu Y; Li G; Wang J; Luo M; Deng Q; Zhang J; Xie Y
    Theranostics; 2019; 9(13):3798-3811. PubMed ID: 31281514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The potential use of serum HBV RNA to guide the functional cure of chronic hepatitis B].
    Lu FM; Wang J; Chen XM; Jiang JN; Zhang WH; Zhao JM; Ren H; Hou JL; Xia NS
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):105-110. PubMed ID: 28297795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
    Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection.
    Yuan L; Liu X; Zhang L; Li X; Zhang Y; Wu K; Chen Y; Cao J; Hou W; Zhang J; Zhu H; Yuan Q; Tang Q; Cheng T; Xia N
    Front Microbiol; 2018; 9():908. PubMed ID: 29867819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.